Christopher S. Kiper
CIK: 0001432744
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIFECORE BIOMEDICAL, INC. \DE\
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Award(A)Direct25.9K shares- - Jul 15, 2025LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Award(A)Direct19.5K shares- - Oct 3, 2024LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Purchase(P)Indirect1.3M shares at avg. $4.10$5.4M - Oct 3, 2024LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Purchase(P)Indirect152.1K shares at avg. $4.10$624K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | Award(A) | 25,907 | - | $0 | Direct |
| Jul 15, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | Award(A) | 19,506 | - | - | Direct |
| Oct 3, 2024 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | Purchase(P) | 1,311,312 | $4.10 | $5,376,379 | Indirect |
| Oct 3, 2024 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | Purchase(P) | 152,102 | $4.10 | $623,618 | Indirect |
1-4 of 4 transactions
About Kiper Christopher S
Kiper Christopher S (SEC CIK 0001432744) files insider reports with the SEC as Director of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
Signal8 holds 3 ownership filings by Kiper Christopher S, all Form 4s, filed between Oct 7, 2024 and Jun 8, 2026. Those filings report 4 transactions, from Oct 3, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kiper Christopher S's filings is in LOS ANGELES, CA.
Recent filings by Kiper Christopher S
Other insiders filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
- OBUS NELSON, Director
- Aryeh Jason, Director
- Schechter Joshua, Director
- Korenberg Matthew E, Director
- Antunes Humberto Calheiros, Director
- Johnson Paul Harold, Director